Burden of off-target infections averted by annual ivermectin mass treatment with ivermectin in Africa.

a These figures are the product of the potential disease burden due to off-target infections in people treated with ivermectin and the assumed effect of ivermectin treatment on the disease burden (see Box 1).
b Estimates for Sudan and South Sudan are merged, as information on the burden per capita was reported for the two together [14].
Figures represent the cumulative burden averted between 1995 and 2010 in areas covered by the African Programme for Onchocerciasis Control.